Fusen Pharmaceutical Co., Ltd. Financial Overview
Fusen Pharmaceutical Co., Ltd.'s market cap is currently HK$558.77M. The company's EPS TTM is HK$-0.034; its P/E ratio is -2.96; Fusen Pharmaceutical Co., Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
